---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/43152521.md"
description: "$LONGBIO-B(01779.HK), $JIANGXI BIO(06915.HK), and $GIANT BIOGENE(02367.HK) placed together: half are waiting for clinical data, while the other half are already making money on shelves. Despite both bearing the 'Biology' label, the gap in commercialization can be a whole body length."
datetime: "2026-08-03T09:53:25.000Z"
locales:
  - [en](https://longbridge.com/en/topics/43152521.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/43152521.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/43152521.md)
author: "[爱吃老鼠药](https://longbridge.com/en/profiles/25865091.md)"
generator: "portal-rs"
---

# $LONGBIO-B(01779.HK), $JIANGXI BIO(06915.HK), and …


### Related Stocks

- [01779.HK](https://longbridge.com/en/quote/01779.HK.md)
- [06915.HK](https://longbridge.com/en/quote/06915.HK.md)
- [02367.HK](https://longbridge.com/en/quote/02367.HK.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**